PANACEABIO Intraday Analysis...

PANACEABIO Share Price

Open 146.40 Change Price %
High 164.70 1 Day 13.15 8.98
Low 143.50 1 Week 32.90 25.98
Close 159.55 1 Month 44.50 38.68
Volume 1285451 1 Year 53.25 50.09
52 Week High 164.70
52 Week Low 83.70
PANACEABIO Important Levels
Resistance 2 179.20
Resistance 1 171.10
Pivot 155.92
Support 1 148.00
Support 2 139.90
NSE INDIA Most Active Stocks
SUZLON 17.50 0.86%
ICICIBANK 257.55 -2.24%
ADANIPOWER 34.75 1.16%
VISESHINFO 0.20 -20.00%
GMRINFRA 12.55 -1.18%
HINDALCO 181.70 5.85%
JPASSOCIAT 10.00 1.52%
AXISBANK 445.00 -1.28%
IDEA 73.35 2.59%
IBREALEST 80.60 -0.86%
More..
NSE INDIA Top Gainers Stocks
BHARATRAS 2279.55 20.00%
PRAKASHSTL 1.80 20.00%
ORIENTHOT 26.75 19.96%
BHAGYNAGAR 25.25 19.95%
OISL 6.05 19.80%
HOVS 161.40 16.03%
KTIL 234.55 12.93%
NAKODA 0.45 12.50%
DLINKINDIA 125.45 11.76%
BLUECHIP 0.50 11.11%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.15 -25.00%
VISESHINFO 0.20 -20.00%
SRGINFOTEC 0.35 -12.50%
HOTELRUGBY 4.10 -11.83%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
SAMTEL 0.50 -9.09%
TECHIN 3.90 -8.24%
More..

Panacea Biotec Limited (NSE: PANACEABIO)

PANACEABIO Technical Analysis 5
As on 23rd Jan 2017 PANACEABIO Share Price closed @ 159.55 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 111.19 & Strong Buy for SHORT-TERM with Stoploss of 120.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
PANACEABIO Target for January
1st Target up-side 129
2nd Target up-side 137.06
3rd Target up-side 145.12
1st Target down-side 106
2nd Target down-side 97.94
3rd Target down-side 89.88
PANACEABIO Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
PANACEABIO Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.panacea-biotec.com
PANACEABIO Address
PANACEABIO
Mohan Co-operative Industrial Estate
B-1 Extn./ A-27
New Delhi, 110044
India
Phone: 91 11 2694 5270
Fax: 91 11 4167 9081
PANACEABIO Latest News
Panacea Biotec: A Turnaround Story   Financial Express   - 04th Feb 15
Panacea Biotec bags Rs. 83 cr order to supply EasyFive-TT vaccine   Hindu Business Line   - 04th Feb 15
Panacea Biotec Announces Collaboration with Rising Pharmaceuticals Inc.   Hindu Business Line   - 19th Dec 14
Panacea Biotec and Apotex form alliance   VC Circle   - 12th Dec 14
Panacea Biotec plans to sell hospital in Gurgaon   VC Circle   - 26th Nov 14
Panacea Biotec Ltd to announce Q2 results on October 31, 2014   Equity Bulls   - 18th Oct 14
Panacea Biotec - Approval of Restructuring proposal under CDR system   Moneycontrol.com   - 29th Sep 14
Panacea Biotec plans to raise up to $42M   VC Circle   - 24th Jul 14
Panacea Biotec bags Unicef order   Hindu Business Line   - 13th Feb 14
Panacea Biotec - Credit Rating   Moneycontrol.com   - 31st Oct 12
Interactive Technical Analysis Chart Panacea Biotec Limited ( PANACEABIO NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Panacea Biotec Limited
PANACEABIO Business Profile
Panacea Biotec is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 620.47 crore.The company has reported a standalone sales of Rs 110.09 crore and a Net Loss of Rs 56.27 crore for the quarter ended Sep 2013.The company management includes Soshil Kumar Jain - Chairman, Ravinder Jain - Managing Director, Rajesh Jain - Joint Managing Director, Sandeep Jain - Joint Managing Director, Sumit Jain - Director, R L Narasimhan - Independent Director, N N Khamitkar - Independent Director, Sunil Kapoor - Independent Director, K M Lal - Independent Director, A N Saksena - Independent Director. It is listed on the BSE with a BSE Code of 531349 and the NSE with an NSE Code of PANACEABIO.Its Registered office is at Ambala-Chandigarh Highway , Lalru,Punjab - 140501.Their Registrars are Skyline Financial Services (p) Ltd.